 Print previewVALIDITY EXPIRED
personal data approved: 2021. VIII. 12. | Publications |
2021
 from data base, 2021. VIII. 12. |
Lazary J., Elemery M., Dome P., Kiss S., Gonda X., Tombor L., Pogany L., Becskereki G., Toth B., Faludi G.: Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder, SCIENTIFIC REPORTS 11: (1) 8867
type of document: Journal paper/Article
language: English
URL |
2019
from data base, 2021. VIII. 12. |
Lazary Judit, Eszlari Nora, Juhasz Gabriella, Bagdy Gyorgy: A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes., JOURNAL OF AFFECTIVE DISORDERS 257: pp. 716-722.
type of document: Journal paper/Article
number of independent citations: 6
language: English
URL |
2016
from data base, 2021. VIII. 12. |
Lazary Judit, Eszlari Nora, Juhasz Gabriella, Bagdy Gyorgy: Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma, EUROPEAN NEUROPSYCHOPHARMACOLOGY 26: (6) pp. 1020-1028.
type of document: Journal paper/Article
number of independent citations: 28
language: English
URL |
2014
from data base, 2021. VIII. 12. |
Lazáry J, Döme P, Csala I, Kovacs G, Faludi G, Kaunisto M, Döme B: Massive Withdrawal Symptoms and Affective Vulnerability Are Associated with Variants of the CHRNA4 Gene in a Subgroup of Smokers, PLOS ONE 9: (1) e87141
type of document: Journal paper/Article
number of independent citations: 15
language: English
URL |
2012
from data base, 2021. VIII. 12. |
Lazary J: Psychopharmacological boundaries of schizophrenia with comorbid cannabis use disorder: a critical review., CURRENT PHARMACEUTICAL DESIGN 18: (32) pp. 4890-4896.
type of document: Journal paper/Review paper
number of independent citations: 6
language: English
URL |
2011
from data base, 2021. VIII. 12. |
Lazary J, Juhasz G, Hunyady L, Bagdy G: Personalized medicine can pave the way for the safe use of CB(1) receptor antagonists., TRENDS IN PHARMACOLOGICAL SCIENCES 32: (5) pp. 270-280.
type of document: Journal paper/Review paper
number of independent citations: 60
language: English
URL |
2011
from data base, 2021. VIII. 12. |
Makkos Z, Fejes L, Inczedy-Farkas G, Kassai-Farkas A, Faludi G, Lazary J: Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency., PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 35: (1) pp. 212-217.
type of document: Journal paper/Article
number of independent citations: 13
language: English
URL |
2011
from data base, 2021. VIII. 12. |
Lazary J, Dome P, Halmai Z, Kruk E, Keszler G, Sarosi A, Sasvari-Szekely M, Faludi G: Epistatic interaction of vascular endothelial growth factor (VEGF) and TNF-alpha gene polymorphisms is associated with major depressive disorder, EUROPEAN NEUROPSYCHOPHARMACOLOGY 21: (Suppl. 3) pp. S240-S241.
type of document:
language: English
|
2009
from data base, 2021. VIII. 12. |
Lazary J, Lazary A, Gonda X, Benko A, Molnar E, Hunyady L, Juhasz G, Bagdy G: Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype, AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 150B: (8) pp. 1118-1127.
type of document: Journal paper/Article
number of independent citations: 47
language: English
URL |
2008
from data base, 2021. VIII. 12. |
Lazary J, Lazary A, Gonda X, Benko A, Molnar E, Juhasz G, Bagdy G: New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype, BIOLOGICAL PSYCHIATRY 64: (6) pp. 498-504.
type of document: Journal paper/Article
number of independent citations: 63
language: English
URL |
| | Number of independent citations to these publications: | 238 |
|
|
Login
yahoo.com
